首页> 外国专利> 3-Di-substd.-amino-vinyl 1-oxa-cephalosporin derivs. - are intermediates for 3-thio-vinyl 1-oxa-cephalosporin(s), having good activity against gram-negative and positive bacteria

3-Di-substd.-amino-vinyl 1-oxa-cephalosporin derivs. - are intermediates for 3-thio-vinyl 1-oxa-cephalosporin(s), having good activity against gram-negative and positive bacteria

机译:3-二-氨基-乙烯基1-氧杂-头孢菌素的衍生物。 -是3-硫代乙烯基1-oxa-头孢菌素的中间体,对革兰氏阴性菌和阳性菌具有良好的活性

摘要

7-R"-7-R2NH-3-R3R4N-CH=CH-4-R1OOC -1-oxa-ceph-2- or 3-em derivs. of formula (I) are new (where the dotted line indicates a double bond in position 2 or 3; the C atom at position 3 may have E or Z stereoisomerism; R1 is an easily removable protecting gp. and (a) R2 is 2-R6NH-thiazol-4-yl-C(=N-OR5)-CO- gp. (Gp.A) or a protected alpha-carboxyarylacetyl radical Ar-CH(COOR'1)-CO-, R'1 is a protecting gp.; Ar is phenyl, opt. protected para-hydroxyphenyl or 2- or 3-thienyl and R" is H or methoxy in position 7-alpha or (b) R2 is an easily removable protecting gp. and R" is H or methoxy in position 7-alpha or H in position 7-beta; R3, R4 independently are alkyl (opt. substd. by alkoxy or dialkylamino) or phenyl or together with the N atom form a 5- or 6-membered satd. heterocyclic gp., opt. contg. a further N, O or S heteroatom and opt. alkyl substd.). Intermediates for the prepn. of 3-thiovinyl -oxacephalosporins of formula (XVIII). This process is described in detail in the specification, but is not claimed (where R is 2-, 3- or 4-pyridyl (including N oxide derivs.), 2-pyrimidyl, 6-methyl-1-oxido-3-pyridazinyl, opt. 4-substd.-5,6-dioxo -1,4,5,6-tetrahydro-1,2,4- triazin-3-yl, 1-alkyl-5,6-dioxo -1,4,5,6-tetrahydro- 1,2,4-triazin-3-yl, 2-alkyl-5,6-dioxo-1,2,5,6 -tetrahydro-1,2,4-triazin-3-yl, opt. 6-substd.-2-alkyl -2,5-dihydro-5-oxo-1,2,4 -triazin-3-yl, 1-amino-1,2-dihydro-2-oxo -4-pyrimidinyl, substd.-1,3,4-thiadiazol-5-yl, 1-substd.-5-tetrazolyl, opt. 3-substd.-1-alkyl-1,3,4 -triazol-5-yl and R' is a gp. derived from Gp.A. Details of the substits. etc. are given). (XVIII) are antibacterials having good activity against both gram-positive and gram-negative bacteria.
机译:式(I)的7-R“ -7-R2NH-3-R3R4N-CH = CH-4-R1OOC -1-oxa-ceph-2-或3-em衍生物是新的(其中虚线表示双位置2或3的键;位置3的C原子可能具有E或Z立体异构体; R1是易于除去的保护基;(a)R2是2-R6NH-噻唑-4-基-C(= N-OR5 )-CO- gp。(Gp.A)或受保护的α-羧芳基乙酰基Ar-CH(COOR'1)-CO-,R'1为保护性gp。; Ar为苯基,优选为受保护的对羟基苯基或2-或3-噻吩基,R”为7-α位的H或甲氧基或(b)R2为易于除去的保护基。R”为7-α位的H或甲氧基或7-β位的H。 R 3,R 4独立地是烷基(优选被烷氧基或二烷基氨基取代)或苯基,或与N原子一起形成5元或6元饱和杂环基,可选地包含另外的N,O或S杂原子式(XVIII)的3-硫代乙烯基-氧杂头孢菌素的制备中间体在说明书中有详细描述,但不要求保护的(其中R是2-,3-或4-吡啶基(包括N氧化物衍生物),2-嘧啶基,6-甲基-1-氧化-3-吡啶并嗪基,同上。 4-取代-5,6-二氧代-1,4,5,6-四氢-1,2,4-三嗪-3-基,1-烷基-5,6-二氧代-1,4,5,6 -四氢-1,2,4-三嗪-3-基,2-烷基-5,6-二氧-1,2,5,6-四氢-1,2,4-三嗪-3-基,opt。 6-亚甲基-2-烷基-2,5-二氢-5-氧代1,2,4-三嗪-3-基,1-氨基-1,2-二氢-2-氧代-4-嘧啶基.-1,3,4-噻二唑-5-基,1-取代-5-四唑基,opt。 3-亚甲基-1-烷基-1,3,4-三唑-5-基,R'为gp。源自Gp.A.替代的详细信息。等)。 (XVIII)是对革兰氏阳性和革兰氏阴性细菌均具有良好活性的抗菌剂。

著录项

  • 公开/公告号FR2505334B1

    专利类型

  • 公开/公告日1984-01-20

    原文格式PDF

  • 申请/专利权人 RHONE POULENC SANTE;

    申请/专利号FR19810009319

  • 发明设计人

    申请日1981-05-11

  • 分类号C07D265/16;

  • 国家 FR

  • 入库时间 2022-08-22 08:45:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号